Citation Impact
Citing Papers
Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma
2009 Standout
Radical Cystectomy in the Treatment of Invasive Bladder Cancer: Long-Term Results in 1,054 Patients
2001 Standout
Risk Factors for Venous Thromboembolism
2003 Standout
Activity of SU11248, a Multitargeted Inhibitor of Vascular Endothelial Growth Factor Receptor and Platelet-Derived Growth Factor Receptor, in Patients With Metastatic Renal Cell Carcinoma
2005 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial
2008 Standout
The natural history of renal carcinoma.
1983
Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial
2007 Standout
Guideline for disinfection and sterilization in healthcare facilities, 2008
2008 Standout
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
2009 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Acute renal failure – definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group
2004 Standout
Laser and photodynamic therapy in the management of cutaneous malignancies
2001
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2024 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
A single‐institution experience with induction and maintenance intravesical docetaxel in the management of non‐muscle‐invasive bladder cancer refractory to bacille Calmette‐Guérin therapy
2009
Concurrent Cisplatin-Based Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer
1999 Standout
EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016
2016 Standout
Transurethral Prostatectomy: Immediate and Postoperative Complications. A Cooperative Study of 13 Participating Institutions Evaluating 3,885 Patients
1989 Standout
Updated concepts and treatment of carcinoma in situ
1998
Ten-Year Prospective Study on the Development of Renal Cell Carcinoma in Dialysis Patients
1990
Long-Term Efficacy Results of EORTC Genito-Urinary Group Randomized Phase 3 Study 30911 Comparing Intravesical Instillations of Epirubicin, Bacillus Calmette-Guérin, and Bacillus Calmette-Guérin plus Isoniazid in Patients with Intermediate- and High-Risk Stage Ta T1 Urothelial Carcinoma of the Bladder
2009
Current perspectives in muscle invasive bladder cancer
2002
Consensus statement on best practice management regarding the use of intravesical immunotherapy with BCG for bladder cancer
2015
Cancer in patients on dialysis for end-stage renal disease: an international collaborative study
1999 Standout
The WHO classification of 1973 is more suitable than the WHO classification of 2004 for predicting survival in pT1 urothelial bladder cancer
2010
Sequential BCG and electromotive mitomycin versus BCG alone for high-risk superficial bladder cancer: a randomised controlled trial
2005
Guidelines on Bladder Cancer
2002
Renal-Cell Carcinoma
1996 Standout
Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity
2004 Standout
The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence
2015 Standout
Accelerated Radiotherapy, Carbogen, and Nicotinamide (ARCON) in the Treatment of Advanced Bladder Cancer: Mature Results of a Phase II Nonrandomized Study
2008
Regression of Metastatic Renal-Cell Carcinoma after Nonmyeloablative Allogeneic Peripheral-Blood Stem-Cell Transplantation
2000 Standout
Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma
2007 Standout
Mechanisms of Action and Clinical Uses of Estramustine
1990
The development of androgen-independent prostate cancer
2001 Standout
Hexaminolevulinate blue-light cystoscopy in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on appropriate use in the USA
2014
EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013
2013 Standout
Plasma clearance of iodine contrast media as a measure of glomerular filtration rate in critically ill patients
2001
Innovations and challenges in renal cancer: Summary statement from the Third Cambridge Conference
2009 StandoutNobel
Cardiovascular toxicity following sunitinib therapy in metastatic renal cell carcinoma: a multicenter analysis
2009
EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2013 Guidelines
2013
Bladder cancer
2016 Standout
Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. The National Cancer Institute of Canada Clinical Trials Group.
1996
Advances in Diagnostic Imaging and Overestimations of Disease Prevalence and the Benefits of Therapy
1993
Prevention of Venous Thromboembolism
2004 Standout
Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma
2007 Standout
Epirubicin
1993
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
Sequential Combination of Mitomycin C Plus Bacillus Calmette-Guérin (BCG) Is More Effective but More Toxic Than BCG Alone in Patients with Non–Muscle-invasive Bladder Cancer in Intermediate- and High-risk Patients: Final Outcome of CUETO 93009, a Randomized Prospective Trial
2014
Renal Carcinoma in Patients Undergoing Nephrectomy: Analysis of Survival and Prognostic Factors
1992
Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder Cancer
2003 Standout
Photodynamic therapy of cancer: An update
2011 Standout
Prevention of Venous Thromboembolism
2008 Standout
Uncomplicated Urinary Tract Infection
2012 Standout
Adjuvant and neoadjuvant chemotherapy for invasive bladder cancer
2000
Polymyalgia Rheumatica and Giant-Cell Arteritis
2002 Standout
EAU Guidelines on Renal Cell Carcinoma: 2014 Update
2015 Standout
Docetaxel and Estramustine Compared with Mitoxantrone and Prednisone for Advanced Refractory Prostate Cancer
2004 Standout
Long-term Outcome of Patients with Frequently Recurrent Non–muscle-invasive Bladder Carcinoma Treated with One Perioperative Plus Four Weekly Instillations of Mitomycin C Followed by Monthly Bacillus Calmette-Guérin (BCG) or Alternating BCG and Interferon-α2b Instillations: Prospective Randomised FinnBladder-4 Study
2015
Metastasis Organotropism: Redefining the Congenial Soil
2019
High-grade Ta urothelial carcinoma and carcinoma in situ of the bladder
2005
Endocrine profiles during administration of the new non‐steroidal anti‐androgen Casodex in prostate cancer
1994
Cardioprotective effects of zofenopril, a new angiotensin-converting enzyme inhibitor, on doxorubicin-induced cardiotoxicity in the rat
2001
Can intravesical bacillus Calmette-Guérin reduce recurrence in patients with superficial bladder cancer? A meta-analysis of randomized trials
2006
HIF activation identifies early lesions in VHL kidneys
2002 StandoutNobel
Tumorigenesis and the angiogenic switch
2003 Standout
EAU Guidelines on Non–Muscle-Invasive Urothelial Carcinoma of the Bladder, the 2011 Update
2011
Quality of Life in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib or Interferon Alfa: Results From a Phase III Randomized Trial
2008
Lymphocyte sensitivity to skeletal muscle in patients with polymyositis and other disorders.
1973
Augmentation of T Cell Levels and Responses Induced by Androgen Deprivation
2004 StandoutNobel
Prevention of High-Dose Chemotherapy–Induced Cardiotoxicity in High-Risk Patients by Angiotensin-Converting Enzyme Inhibition
2006 Standout
Intravesical Bacillus Calmette-Guérin versus epirubicin for Ta and T1 bladder cancer
2011
Large Artery Involvement in Giant Cell (Temporal) Arteritis
1975
The Spectrum of Vasculitis
1978 Standout
Infectious Diseases Society of America Guidelines for the Diagnosis and Treatment of Asymptomatic Bacteriuria in Adults
2005 Standout
Kidney Preserving Surgery in Renal Cell Tumors: Indications, Techniques and Results in 152 Patients
1993
The coregulator exchange in transcriptional functions of nuclear receptors
2000 Standout
Bladder Cancer
2020 Standout
Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: A Systematic Review and Two-Step Meta-Analysis
2016
Promotion of agonist activity of antiandrogens by the androgen receptor coactivator, ARA70, in human prostate cancer DU145 cells
1998
Radical Extensive Surgery for Renal Cell Carcinoma: Long-Term Results and Prognostic Factors
1990
Is Routine Excretory Urography Necessary at First Diagnosis of Bladder Cancer?
1997
Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Agents: Results From a Large, Multicenter Study
2009 Standout
Radical Cystectomy for Bladder Cancer Today—A Homogeneous Series Without Neoadjuvant Therapy
2003 Standout
Complications and Long-Term Results of Salvage Cystectomy After Failed Bladder Sparing Therapy for Muscle Invasive Bladder Cancer
2011
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
Activation of adriamycin by the pH-dependent formaldehyde-releasing prodrug hexamethylenetetramine.
2003
Antimicrobial Agents in Transurethral Prostatic Resection
1987
UPPER URINARY TRACT TUMORS AFTER PRIMARY SUPERFICIAL BLADDER TUMORS: PROGNOSTIC FACTORS AND RISK GROUPS
2000
Best Practice Policy Statement on Urologic Surgery Antimicrobial Prophylaxis
2008
Survival and Prognostic Stratification of 670 Patients With Advanced Renal Cell Carcinoma
1999 Standout
Temporal Arteritis and Polymyalgia Rheumatica
1972
Radical Cystectomy for Carcinoma of the Bladder: Critical Evaluation of the Results in 1,026 Cases
1997
THE CURRENT STATUS OF BLADDER PRESERVATION IN THE TREATMENT OF MUSCLE INVASIVE BLADDER CANCER
2000
Works of Sverker Hellsten being referenced
Nordic Prospective Trials of Radical Cystectomy and Neoadjuvant Chemotherapy
1998
Bacillus Calmette-Guérin Is Superior to a Combination of Epirubicin and Interferon-α2b in the Intravesical Treatment of Patients with Stage T1 Urinary Bladder Cancer. A Prospective, Randomized, Nordic Study
2009
Guidelines on Renal Cell Cancer
2001
Clinically Unrecognized Renal Cell Carcinoma
1990
Alternating Mitomycin C and BCG Instillations versus BCG Alone in Treatment of Carcinoma in Situ of the Urinary Bladder: A Nordic Study
2003
A Systematic Overview of Radiation Therapy Effects in Urinary Bladder Cancer
2003
Current Status of Epirubicin (Farmorubicin) in the Treatment of Solid Tumours
1990
Species Distribution and Antibiotic Sensitivity of Bacteria Isolated Pre- and Postoperatively from Patients Undergoing Transurethral Prostatic Resection
1984
The Effectiveness of a Short Perioperative Course with Pivampicillin/Pivmecillinam in Transurethral Prostatic Resection: Clinical Results
1986
Unrecognized Renal Cell Carcinoma
1981
Cardiovascular Complications of Estrogen Therapy for Nondisseminated Prostatic Carcinoma: A Preliminary Report from a Randomized Multicenter Study
1986
Carcinoma of the Renal Pelvis and Ureter Following Bladder Carcinoma: Frequency, Risk Factors and Clinicopathological Findings
1989
Estimating kidney function during urography. Comparison of contrast medium clearance and simultaneous 51Cr-EDTA clearance.
1988
Neoadjuvant Chemotherapy in Bladder Cancer: A Randomized Study
1993
Clinically unrecognized renal cell carcinoma. An autopsy study.
1982
Laser Treatment of Localized Squamous Cell Carcinoma of the Penis
1995
Controlled trial of a short and a prolonged course with ciprofloxacin in patients undergoing transurethral prostatic surgery
1987
Five-year followup of a prospective trial of radical cystectomy and neoadjuvant chemotherapy: Nordic Cystectomy Trial I. The Nordic Cooperative Bladder Cancer Study Group.
1996
“Polymyalgia arteritica”. Further clinical and histopathological studies with a report of six autopsy cases.
1968
Prevention of recurrent acute cystitis by methenamine hippurate: double blind controlled crossover long term study.
1987
Long‐term Follow‐up after Transurethral Prostatic Resection With or Without a Short Peri‐operative Antibiotic Course
1985
Clinically Unrecognised Renal Carcinoma: Aspects of Tumour Morphology, Lymphatic and Haematogenous Metastatic Spread
1983
Intravesical Adriamycin Therapy in Carcinoma in Situ of the Urinary Bladder
1984
Five-year Followup of a Prospective Trial of Radical Cystectomy and Neoadjuvant Chemotherapy: Nordic Cystectomy Trial 1
1996
Results of second-look resection after primary resection of T1 tumour of the urinary bladder
2005
Unrecognized Renal Cell Carcinoma
1981
T1 G1 urinary bladder carcinoma: Fact or fiction?
2005
Concentrations of cefotaxime in serum, urine and tissues of urological patients
1981
Lymphatogenous Spread of Renal Cell Carcinoma: An Autopsy Study
1997
A Short Antibiotic Course Given in Conjunction with and after Catheter Removal Consecutive to Transurethral Prostatic Resection
1984
The Effect of a Short Antibiotic Course in Transurethral Prostatic Resection
1984